Markus Boehringer

1.4k total citations
11 papers, 898 citations indexed

About

Markus Boehringer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Markus Boehringer has authored 11 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Markus Boehringer's work include Diabetes Treatment and Management (7 papers), Peptidase Inhibition and Analysis (6 papers) and Neuropeptides and Animal Physiology (5 papers). Markus Boehringer is often cited by papers focused on Diabetes Treatment and Management (7 papers), Peptidase Inhibition and Analysis (6 papers) and Neuropeptides and Animal Physiology (5 papers). Markus Boehringer collaborates with scholars based in Switzerland, United States and Israel. Markus Boehringer's co-authors include Thomas Luebbers, Daniel Bur, Werner Klaus, Dirk Kostrewa, Holger Kuehne, Francis Mueller, Hans Gmuender, Walter Huber, E Seböková and Gianni Gromo and has published in prestigious journals such as Biochemistry, Cell stem cell and Journal of Medicinal Chemistry.

In The Last Decade

Markus Boehringer

11 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Boehringer Switzerland 10 588 209 170 158 147 11 898
Ross Weatherman United States 16 662 1.1× 338 1.6× 230 1.4× 86 0.5× 125 0.9× 25 1.3k
Inge Thøger Christensen Denmark 15 328 0.6× 98 0.5× 89 0.5× 179 1.1× 60 0.4× 18 603
Andrew J. Peat United States 20 705 1.2× 683 3.3× 59 0.3× 69 0.4× 232 1.6× 36 1.5k
Lihu Yang United States 19 501 0.9× 449 2.1× 182 1.1× 32 0.2× 174 1.2× 39 1.1k
Stephen L. Gwaltney United States 17 478 0.8× 540 2.6× 391 2.3× 79 0.5× 350 2.4× 25 1.3k
Luc Roumen Netherlands 16 464 0.8× 80 0.4× 239 1.4× 185 1.2× 79 0.5× 21 736
Herman H. Stein United States 20 652 1.1× 548 2.6× 105 0.6× 68 0.4× 99 0.7× 59 1.3k
Markus Pietsch Germany 20 461 0.8× 348 1.7× 68 0.4× 97 0.6× 26 0.2× 53 982
Andy Merritt United Kingdom 15 430 0.7× 224 1.1× 71 0.4× 172 1.1× 24 0.2× 32 816
Athena Sudom United States 16 344 0.6× 210 1.0× 83 0.5× 56 0.4× 96 0.7× 21 809

Countries citing papers authored by Markus Boehringer

Since Specialization
Citations

This map shows the geographic impact of Markus Boehringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Boehringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Boehringer more than expected).

Fields of papers citing papers by Markus Boehringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Boehringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Boehringer. The network helps show where Markus Boehringer may publish in the future.

Co-authorship network of co-authors of Markus Boehringer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Boehringer. A scholar is included among the top collaborators of Markus Boehringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Boehringer. Markus Boehringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ben‐David, Uri, Tamar Golan‐Lev, Payal Arora, et al.. (2013). Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen. Cell stem cell. 12(2). 167–179. 250 indexed citations
2.
Bénardeau, Agnès, Jörg Benz, Alfred Binggeli, et al.. (2009). Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes. Bioorganic & Medicinal Chemistry Letters. 19(9). 2468–2473. 85 indexed citations
3.
Mattei, Patrizio, Markus Boehringer, Holger Fischer, et al.. (2009). Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 20(3). 1109–1113. 54 indexed citations
4.
Boehringer, Markus, Holger Fischer, Michael Hennig, et al.. (2009). Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1106–1108. 38 indexed citations
5.
Seböková, E, Andreas Christ, Markus Boehringer, & Jacques Mizrahi. (2007). Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes. Current Topics in Medicinal Chemistry. 7(6). 547–555. 59 indexed citations
6.
Peters, Jens‐Uwe, Daniel Hunziker, Holger Fischer, et al.. (2004). An aminomethylpyrimidine DPP-IV inhibitor with improved properties. Bioorganic & Medicinal Chemistry Letters. 14(13). 3575–3578. 25 indexed citations
7.
Peters, Jens‐Uwe, et al.. (2004). Aminomethylpyrimidines as novel DPP-IV inhibitors: A 105-fold activity increase by optimization of aromatic substituents. Bioorganic & Medicinal Chemistry Letters. 14(6). 1491–1493. 68 indexed citations
8.
Peters, Jens‐Uwe, et al.. (2004). Aminomethylpyridines as DPP-IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(13). 3579–3580. 19 indexed citations
9.
Peters, Jens‐Uwe, et al.. (2004). Aminomethylpyridines as DPP‐IV Inhibitors.. ChemInform. 35(41). 1 indexed citations
10.
11.
Boehringer, Markus, Daniel Bur, Hans Gmuender, et al.. (2000). Novel Inhibitors of DNA Gyrase:  3D Structure Based Biased Needle Screening, Hit Validation by Biophysical Methods, and 3D Guided Optimization. A Promising Alternative to Random Screening. Journal of Medicinal Chemistry. 43(14). 2664–2674. 286 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross Weatherman Breakdown of academic impact, for papers by Inge Thøger Christensen Breakdown of academic impact, for papers by Andrew J. Peat Breakdown of academic impact, for papers by Lihu Yang Breakdown of academic impact, for papers by Stephen L. Gwaltney Breakdown of academic impact, for papers by Luc Roumen Breakdown of academic impact, for papers by Herman H. Stein Breakdown of academic impact, for papers by Markus Pietsch Breakdown of academic impact, for papers by Andy Merritt Breakdown of academic impact, for papers by Athena Sudom
Rankless by CCL
2026